Dysmenorrhea - Drug Pipeline Analysis And Market Forecasts To 2016---aarkstore Enterprise Market Res

Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

Dysmenorrhea - Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global dysmenorrhea market. The report identifies the key trends shaping and driving the global dysmenorrhea market. The report also provides insight into the prevalent competitive landscape and the emerging players expected to bring a significant shift in the positioning of the existing market leaders. Most importantly, the report provides valuable insight into the pipeline products within the global dysmenorrhea sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by team of industry experts

The global dysmenorrhea therapeutics market was valued at $1.7 billion in 2009. It is expected to grow at a Compound Annual Growth Rate (CAGR) of 3.9% by 2016. This slow growth is primarily attributed to due to the lack of diagnostic techniques, disease awareness and the poor safety and efficacy profiles of the existing therapies. The current competitive landscape consists of only generics and off-label therapies, none of which have a dominant position. The current emphasis has been on treating the symptoms of the disease without providing an absolute cure.

Scope

The scope of the report includes:

- Annualized global dysmenorrhea market revenues data from 2001 to 2009, forecast forward for seven years to 2016.

- Geographies covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France and Japan.

- Pipeline analysis data providing a split across different phases by the mechanism of action being developed and emerging trends. Key classes of mechanism of action include prostaglandin synthetase inhibitors and COX-2 inhibitors.

- Analysis of the current and future market competition in the global dysmenorrhea market. Key market players covered are China Aoxing Pharmaceutical Company, Vantia Therapeutics, Columbia Laboratories, Merck and Bayer Schering Pharma AG.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessments, market characterization, the unmet needs and the implications for the future market associated with dysmenorrhea.

For more information, please visit:

http://www.aarkstore.com/reports/Dysmenorrhea-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016-42040.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

by: Aarkstore Enterprise

POST COMMENT

Tw Organisatie Awakens The World To The Wonders Of Direct Marketing How to Make More Money with Affiliate Marketing: 3 Important Tips Saving Your Sexless Marriage Scam or Any Good? How To Cure Sexless Marriages How you can profit from printed items Top 5 Tips For Effective Email Marketing -purchase articles Using Promotional Gifts To Market Your Company Use Email Marketing wisely; Stand out from Junk Mail -articles buy How to Determine Whether to buy into the Property Market How to make money with affiliate marketing - affiliate marketing proven strategies Viral Marketing At Its Best -articles for sale Why do email marketing -article for sale U.k Currency Report-market Report! 4 Amazing Steps To Unleashing The Massive Profits Within Solo Ads Fast And Easily. -plr article